a Département de médecine générale, Sorbonne Paris Cité , Univ. Paris Diderot , Paris , France.
b Département de médecine générale , Univ. Bordeaux , Bordeaux , France.
Eur J Gen Pract. 2018 Dec;24(1):60-67. doi: 10.1080/13814788.2017.1400529. Epub 2017 Nov 27.
Many people in Europe remain undiagnosed for human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV).
To evaluate acceptability and effectiveness of a questionnaire designed to facilitate identification of risk factors for these viruses.
We performed an observational study, in a prospectively enrolled cohort of patients in Paris (France) seen in 2014. Eighteen GPs administered a questionnaire to the first 50 patients, collecting information about risk factors. GPs were randomized into two groups: A (self-administered questionnaire) and B (GP-administered questionnaire). We used the overall response rate to assess the acceptability of the questionnaire. We used the rate of newly identified risk factors and compared the number of tests performed one year before and immediately after the intervention to assess the effectiveness of the questionnaire.
842 patients were randomized: 349 (41.5%) in group A and 493 (58.5%) in group B. Acceptability was 88.5% (95%CI: 86.3-90.6); 93.1% (95%CI: 90.5-95.8) in-group A and 85.2% (95%CI: 82.1-88.3) in group B (P = 0.0004). Prevalence of risk factors was 51.8% (95%CI: 48.2-54.4) and 58.3% were newly identified (95%CI: 52.9-63.7). The number of HIV tests performed during the four weeks after intervention increased by 27% compared to the same period one year before (P = 0.22). It increased by 113% (P = 0.005) and 135% (P = 0.005) for HBV and HCV, respectively.
The questionnaire proved acceptable and effective in identifying risk factors for HIV, HBV and HCV in general practice.
在欧洲,许多人仍然未被诊断出患有人类免疫缺陷病毒(HIV)、乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)。
评估一种旨在确定这些病毒危险因素的问卷的可接受性和有效性。
我们在 2014 年进行了一项观察性研究,纳入了巴黎(法国)的前瞻性登记队列中的 50 名患者。18 名全科医生向第一批 50 名患者发放问卷,收集有关危险因素的信息。全科医生被随机分为两组:A 组(自我管理问卷)和 B 组(医生管理问卷)。我们使用总体应答率来评估问卷的可接受性。我们使用新确定的危险因素的发生率,并比较干预前后一年的检测数量来评估问卷的有效性。
共 842 名患者被随机分配:A 组 349 名(41.5%),B 组 493 名(58.5%)。问卷的可接受性为 88.5%(95%CI:86.3-90.6);A 组为 93.1%(95%CI:90.5-95.8),B 组为 85.2%(95%CI:82.1-88.3)(P=0.0004)。危险因素的患病率为 51.8%(95%CI:48.2-54.4),58.3%为新发现的危险因素(95%CI:52.9-63.7)。与干预前一年同期相比,干预后四周内进行的 HIV 检测数量增加了 27%(P=0.22)。HBV 和 HCV 的检测数量分别增加了 113%(P=0.005)和 135%(P=0.005)。
该问卷在全科医学中证明了其识别 HIV、HBV 和 HCV 危险因素的可接受性和有效性。